Nicotinamide decreases cytokine-induced activation of orbital fibroblasts from patients with thyroid-associated ophthalmopathy

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 1, 1998, Pages 121-124

  Hiromatsu, Yuji ^a   Yang, Damu ^a   Miyake, Ikuyo ^a   Koga, Mari ^a   Kameo, Junko ^a   Sato, Masayuki ^a   Inoue, Yoichi ^b   Nonaka, Kyohei ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Olympia Medical Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; NICOTINAMIDE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL ACTIVATION; DRUG EFFECT; ENDOCRINE OPHTHALMOPATHY; FIBROBLAST; GRAVES DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; ORBIT; PRIORITY JOURNAL;

EID: 0031795562     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.1.4478     Document Type: Article

References (24)

1. Wall JR, Salvi M, Bernard NF, Boucher A, Haegert D. 1991 Thyroid-associated ophthalmopathy - a model for the association of organ-specific autoimmune disorders. Immunol Today. 12:150-153.
2. Weetman AP. 1991 Thyroid-associated eye disease: pathophysiology. Lancet. 338:25-28.
3. Gorman CA. 1994 Pathogenesis of Graves' ophthalmopathy. Thyroid. 4:379-383.
4. Heufelder AE, Bahn RS. 1993 Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest. 23:10-17.
5. McLachlan SM, Prummel MF, Rapoport B. 1994 Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. J Clin Endocrinol Metab. 78:1070-1074.
6. Hiromatsu Y. 1996 In situ studies of orbital tissue from patients with thyroid-associated ophthalmopathy. Orbit. 15:147-158.
7. Heufelder AE, Bahn RS. 1992 Modulation of intercellular adhesion molecule-1 (ICAM-1) by cytokines and Graves' IgGs in cultured Graves' retroocular fibroblasts. Eur J Clin Invest. 22:529-537.
8. Heufelder AE, Bahn RS, Boergen KP, Scriba PC. 1993 Nachweis, lokalisation und modulation der CD44/hyaluronsaure-rezeptor expression bei patienten mit endocriner orbitopathie. Med Klin. 88:181-185.
9. Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H, Tarui S. 1982 Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis: an observation in nonobese diabetic (NOD) mice. Diabetes. 31:749-753.
10. Elliott RB, Chase HP. 1991 Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia. 34:362-365.
11. Pozzilli P, Visalli N, Signore A, et al. 1995 Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study). Diabetologia 38:848-852.
12. Yamada K, Miyajima E, Nonaka K. 1990 Inhibition of cytokine-induced MHC class II but class I molecule expression on mouse islet cells by niacinamide and 3-aminobenzamide. Diabetes. 39:1125-1130.
13. Hiromatsu Y, Sato M, Yamada K, Nonaka K. 1991 Inhibitory effects of nicotinamide on recombinant human interferon-gamma-induced intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigen expression on cultured human endothelial cells. Immunol Lett. 31:35-40.
14. Hiromatsu Y, Sato M, Yamada K, Nonaka K. 1992 Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-γ-induced HLA-DR antigen expression, but not HLA-A,B,C antigen expression, on cultured human thyroid cells. Clin Endocrinol (Oxf). 36:91-95.
15. Hiromatsu Y, Sato M, Tanaka K, Ishisaka N, Kamachi J, Nonaka K. 1993 Inhibitory effects of nicotinamide on intercellular adhesion molecule-1 expression on cultured human thyroid cell. Immunology. 80:330-332.
16. Nagata S, Golstein P. 1995 The fas death factor. Science. 267:1449-1456.
17. Hiromatsu Y, Fukazawa H, Guinard F, Salvi M, How J, Wall JR. 1988 A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 67:565-570.
18. Shall S. 1984 ADP-ribose in DNA repair: a new component of DNA excision repair. Adv Radiat Biol. 11:1-69.
19. Onashi Y, Ueda K, Hayaishi O, Ikai K, Niwa O. 1984 Induction of murine teratocarcinoma cell differentiation by suppression of poly (ADP-ribose) synthesis. Proc Natl Acad Sci USA. 81:7132-7136.
20. Taniguchi T, Agemori M, Kameshita I, Nishikimi M, Shizuta Y. 1982 Participation of poly(ADP-ribosyl)ation in the depression of RNA synthesis caused by treatment of mouse lymphoma cells with methylnitrosourea. J Biol Chem. 257:4027-4030.
21. LeDoux SP, Hall CR, Forbes PM, Patton NJ, Wilson GL. 1988 Mechanisms of nicotinamide and thymidine protection from alloxan and streptozotocin toxicity. Diabetes. 37:1015-1019.
22. Martin A, Huber GK, Davies TF. 1990 Induction of human thyroid cell ICAM-1 (CD54) antigen expression and ICAM-1-mediated lymphocyte binding. Endocrinology. 127:651-657.
23. Makgoba MW, Sanders ME, Ginther Luce GE, et al. 1988 ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature. 331:86-88.
24. Koga M, Sato M, Migita M, Nonaka K. Immunohistochemical detection of apoptosis in autoimmune thyroid disorder. Proc of the 11th International Thyroid Congress, Toronto, Thyroid, 1995, [Suppl 1]: p S-149.